Indeed, in the analysis of occult cancer tissue identified during RRSO which is considered to be the earliest HGSC, LCN2 also showed corresponding localization with the aberrant p53 staining, indicating that the increased expression of LCN2 is associated with the early stages of HGSC carcinogenesis. The gene discussed is LCN2; the disease is cancer.